Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease

There are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarrete-Dechent, Cristián, Majerson, Daniela, Torres, Marisa, Armijo, Daniela, Patel, Mahir, Menter, Alan, de la Cruz, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540541/
https://www.ncbi.nlm.nih.gov/pubmed/26312707
http://dx.doi.org/10.1590/abd1806-4841.20153538
_version_ 1782386264061771776
author Navarrete-Dechent, Cristián
Majerson, Daniela
Torres, Marisa
Armijo, Daniela
Patel, Mahir
Menter, Alan
de la Cruz, Claudia
author_facet Navarrete-Dechent, Cristián
Majerson, Daniela
Torres, Marisa
Armijo, Daniela
Patel, Mahir
Menter, Alan
de la Cruz, Claudia
author_sort Navarrete-Dechent, Cristián
collection PubMed
description There are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who was treated with biologic therapies. After one year of treatment with biologic agents, the patient was diagnosed with Chagas Disease.
format Online
Article
Text
id pubmed-4540541
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-45405412015-08-20 Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease Navarrete-Dechent, Cristián Majerson, Daniela Torres, Marisa Armijo, Daniela Patel, Mahir Menter, Alan de la Cruz, Claudia An Bras Dermatol Case Report There are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who was treated with biologic therapies. After one year of treatment with biologic agents, the patient was diagnosed with Chagas Disease. Sociedade Brasileira de Dermatologia 2015 /pmc/articles/PMC4540541/ /pubmed/26312707 http://dx.doi.org/10.1590/abd1806-4841.20153538 Text en © 2015 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Navarrete-Dechent, Cristián
Majerson, Daniela
Torres, Marisa
Armijo, Daniela
Patel, Mahir
Menter, Alan
de la Cruz, Claudia
Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title_full Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title_fullStr Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title_full_unstemmed Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title_short Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
title_sort use of tumor necrosis factor alpha (tnf α) antagonists in a patient with psoriasis and chagas disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540541/
https://www.ncbi.nlm.nih.gov/pubmed/26312707
http://dx.doi.org/10.1590/abd1806-4841.20153538
work_keys_str_mv AT navarretedechentcristian useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT majersondaniela useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT torresmarisa useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT armijodaniela useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT patelmahir useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT menteralan useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease
AT delacruzclaudia useoftumornecrosisfactoralphatnfaantagonistsinapatientwithpsoriasisandchagasdisease

Ejemplares similares